On June 10, 2025, Klotho Neurosciences, Inc. announced a temporary reduction of the exercise price for its Public Warrants from $3.49 to $1.35, valid from June 10 to June 20, 2025. Additionally, they corrected a prior report stating that a stock purchase agreement on June 5, 2025, involved the sale of 6,250,000 shares for $500,000.